Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:chemical_compound
|
| gptkbp:activities |
immune checkpoint inhibition
|
| gptkbp:clinical_trial |
Phase 1
|
| gptkbp:developed_by |
gptkb:Allergan
|
| https://www.w3.org/2000/01/rdf-schema#label |
ALX-0716
|
| gptkbp:is_tested_for |
clinical trials
|
| gptkbp:is_used_for |
gptkb:healthcare_organization
|
| gptkbp:manager |
intravenous
|
| gptkbp:related_to |
gptkb:vaccine
|
| gptkbp:status |
investigational
|
| gptkbp:targets |
gptkb:PD-1
|
| gptkbp:bfsParent |
gptkb:Ablynx
|
| gptkbp:bfsLayer |
4
|